AdCh63-ME-TRAP

N/A

Report date: 2024/06/11 20:00:08

Base Information

Drug NameAdCh63-ME-TRAP
Drug Alias NamePlaMavaxChAd63-ME-TRAPChAd63-MVA-ME-TRAPMVA-ME-TRAP
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria, FalciparumMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySenegalUnited KingdomBurkina Faso +[5] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcReithera SrlUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Oxford
Active IndicationsN/A
Inactive IndicationsMalaria, FalciparumMalaria

Other Information

ATC CodeN/A
Related LinksN/A